+499.5%
MRNA vs BBY
+27.1%
+472.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +3.2% | -5.4% | -3.8% |
| 7D | +5.5% | +9.5% | -4.0% | +0.7% |
| 30D | +158.7% | +6.8% | +151.9% | +155.2% |
| 3M | +182.1% | +28.9% | +153.3% | +167.0% |
| 6M | +151.8% | +37.8% | +114.0% | +133.1% |
| YTD | +393.6% | +38.7% | +354.8% | +355.7% |
| 1Y | +499.5% | +23.7% | +475.8% | +494.7% |
| All | +499.5% | +27.1% | +472.4% | +494.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BBY.
Daily Out/Under-Performance
Portfolio return minus BBY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling